ASH Impact Series: Hetty Carraway, MD - Treatment of Patients with High Grade MDS
465 views · Published 11 January 2017 · 3:30 · Indexed 24 October 2026
Channel: American Society of Hematology · 2017 · Nonprofits & Activism
Hetty Carraway, MD, discusses the prognostic scoring system for patients diagnosed with high grade MDS, the role of hypomethylating agents in these patients, how you define treatment response and failure to these agents, and more. Dr. Carraway presented on the topic at the 2016 ASH Meeting on Hematologic Malignancies in a session titled "How I Treat High Grade MDS." Visit https://ashondemand.org/ for more on this topic and to watch other educational videos from ASH.
More from this channel
-
1:52
Ron Reagan Accepts ASH Award - Stem Cell Research
-
4:25
Sen. Jim Talent's Work on Sickle Cell Disease Legislation
-
3:56
ASH and the Reagans Support Stem Cell Research
-
5:42
The American Society of Hematology Celebrates its 50th Anniversary
-
5:57
David Nathan Receives 2011 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
5:17
James George Receives 2012 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
2:21
Congress: Protect NIH funding
-
2:21
Act Now: Tell Congress to Stop Further Cuts to Research Funding